The STI panel includes detection of several critical pathogens such as Chlamydia trachomatis, Herpes Simplex Virus 1 (HHV-1), Herpes Simplex Virus 2 (HHV-2), Neisseria gonorrhoeae, Ureaplasma urealyticum, Mycoplasma genitalium, Trichomonas vaginalis, Treponema pallidum, and Haemophilus ducreyi. Additionally, it screens for high-risk HPV types, specifically HPV 16, HPV 18, and HPV 45.

By offering comprehensive coverage of these pathogens, the Express Gene™ STI panel ensures accurate and thorough detection of sexually transmitted infections. This helps healthcare providers to diagnose infections promptly and prescribe appropriate treatments, thereby reducing the risk of complications and transmission. The inclusion of high-risk HPV types is particularly crucial for identifying potential risks of cervical and other cancers, allowing for early intervention and better patient management.

The Express Gene™ STI panel is a valuable resource for clinicians dedicated to providing effective care for patients with sexually transmitted infections, supporting public health efforts to control and prevent the spread of STIs.